[go: up one dir, main page]

CA2420593A1 - Recepteurs du facteur de necrose tumorale 6$g(a) et 6$g(b) - Google Patents

Recepteurs du facteur de necrose tumorale 6$g(a) et 6$g(b) Download PDF

Info

Publication number
CA2420593A1
CA2420593A1 CA002420593A CA2420593A CA2420593A1 CA 2420593 A1 CA2420593 A1 CA 2420593A1 CA 002420593 A CA002420593 A CA 002420593A CA 2420593 A CA2420593 A CA 2420593A CA 2420593 A1 CA2420593 A1 CA 2420593A1
Authority
CA
Canada
Prior art keywords
amino acid
tnfr
seq
polypeptide
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002420593A
Other languages
English (en)
Inventor
Reiner L. Gentz
Reinhard Ebner
Guo-Liang Yu
Steven M. Ruben
Jian Ni
Ping Feng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2420593A1 publication Critical patent/CA2420593A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Cette invention se rapporte à de nouvelles protéines servant de récepteurs du facteur de nécrose tumorale (TNFR). Cette invention concerne en particulier des molécules d'acide nucléique isolées codant les protéines servant de TNFR 6.alpha. et 6.beta. humains. Cette invention décrit en particulier des polypeptides TNFR 6.alpha. et 6.beta., ainsi que des vecteurs, des cellules hôtes et des procédés de recombinaison servant à leur production. Cette invention concerne enfin des procédés de criblage pour identifier des agonistes et des antagonistes de l'activité des TNFR 6.alpha. et 6.beta., ainsi que des procédés diagnostiques permettant de détecter des troubles liés au système immunitaire et des procédés thérapeutiques servant à traiter des troubles liés au système immunitaire.
CA002420593A 2000-08-25 2001-08-24 Recepteurs du facteur de necrose tumorale 6$g(a) et 6$g(b) Abandoned CA2420593A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US22759800P 2000-08-25 2000-08-25
US60/227,598 2000-08-25
US25213100P 2000-11-21 2000-11-21
US60/252,131 2000-11-21
US30322401P 2001-07-06 2001-07-06
US60/303,224 2001-07-06
PCT/US2001/026396 WO2002018622A2 (fr) 2000-08-25 2001-08-24 Recepteurs du facteur de necrose tumorale 6$g(a) et 6$g(b)

Publications (1)

Publication Number Publication Date
CA2420593A1 true CA2420593A1 (fr) 2002-03-07

Family

ID=27397742

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002420593A Abandoned CA2420593A1 (fr) 2000-08-25 2001-08-24 Recepteurs du facteur de necrose tumorale 6$g(a) et 6$g(b)

Country Status (4)

Country Link
EP (1) EP1322667A4 (fr)
AU (1) AU2001286688A1 (fr)
CA (1) CA2420593A1 (fr)
WO (1) WO2002018622A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190390278A1 (en) * 2017-01-26 2019-12-26 Oklahoma Medical Research Foundation Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE92107T1 (de) * 1989-04-29 1993-08-15 Delta Biotechnology Ltd N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen.
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
GB9526733D0 (en) * 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
CA2277925A1 (fr) * 1997-01-14 1998-07-16 Human Genome Sciences, Inc. Recepteurs 6.alpha. et 6.beta. du facteur de necrose tumorale
US5885800A (en) * 1997-02-04 1999-03-23 Smithkline Beecham Corporation DNA encoding tumor necrosis related receptor, TR4
ATE393222T1 (de) * 1997-09-18 2008-05-15 Genentech Inc Dcr3 polypeptid, ein tnfr homolog
CA2324517A1 (fr) * 1998-03-30 1999-10-07 Eli Lilly And Company Applications therapeutiques de polypeptides mflint murs, ou de opg3 en tant que membre de la superfamille du recepteur du tnf

Also Published As

Publication number Publication date
WO2002018622A2 (fr) 2002-03-07
WO2002018622A3 (fr) 2002-08-29
EP1322667A2 (fr) 2003-07-02
AU2001286688A1 (en) 2002-03-13
EP1322667A4 (fr) 2004-08-18

Similar Documents

Publication Publication Date Title
US7186800B1 (en) Tumor necrosis factor 6α and 6β
US7709218B2 (en) Tumor necrosis factor receptors 6α and 6β
US6902910B2 (en) Death domain containing receptor 4
US7708996B2 (en) DR3 antibodies
US7511017B2 (en) Methods of treatment with TNFR5
US6951738B2 (en) Human tumor necrosis factor receptors TR13 and TR14
US20060234285A1 (en) Tumor Necrosis Factor Receptors 6 Alpha & 6 Beta
CA2371114A1 (fr) Recepteurs contenant un domaine de mort cellulaire
CA2373063A1 (fr) Recepteur 4 contenant le domaine de la mort cellulaire programmee
AU774845B2 (en) Tumor necrosis factor receptors 6alpha and 6beta
US6713061B1 (en) Death domain containing receptors
WO2000071150A1 (fr) Recepteur 5 du facteur de necrose tumorale
WO2000073321A9 (fr) Tr10, recepteur de facteur de necrose tumorale humain
US20020098163A1 (en) Human tumor necrosis factor receptors TR21 and TR22
CA2420593A1 (fr) Recepteurs du facteur de necrose tumorale 6$g(a) et 6$g(b)

Legal Events

Date Code Title Description
FZDE Dead